NuMeRI is a not-for-profit company, providing a framework to consolidate expertise and to implement new strategic initiatives in nuclear medicine technologies and biosciences. This will create significant Research, Development and Innovation (RD& I) capacity in South Africa.
NuMeRI is a one-stop-shop medical imaging facility dedicated to drug development and clinical research.
This core research network is embedded within the healthcare domain, which lends to a mutually beneficial environment for medical research and general practice – with public health being the common goal. The research conducted at NuMeRI will contribute to the development of a range of therapies that address the national priority disease.
NuMeRI’s effectiveness will be measured in terms of research, innovation and value generation in areas of country- and region-specific health challenges.
NuMeRI will be instrumental in capacitating the public healthcare sector with critical / scarce skilled medical professionals through the provision of key infrastructure that is unique to their field(s).
The very nature of NuMeRI’s research activities necessitates a coalescence of their objectives with the priorities of the National Department of Health.
NuMeRI Board of directors:
Dr. Nozipho E. Nyakale (Chair)
Prof. Mike Sathekge (CEO)
Prof. Jan Rijn Zeevaart
Prof. Arthur Rantloane
Dr. Joseph Mangwane